# Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

> **NCT00081328** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 699 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Metformin
- **DRUG:** Rosiglitazone
- **BEHAVIORAL:** Lifestyle Program

## Key facts

- **NCT ID:** NCT00081328
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2011-02
- **Final completion:** 2014-02
- **Target enrollment:** 699 (ACTUAL)
- **Last updated:** 2021-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081328, "Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00081328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*